| Page 6 | Kisaco Research
 

Dr Angela Jones

Co-CEO
Petscribers

Dr Angela Jones

Co-CEO
Petscribers

Dr Angela Jones

Co-CEO
Petscribers
 

Jasdeep Singh

CEO
SingleTimeMicroneedles

Jasdeep Singh

CEO
SingleTimeMicroneedles

Jasdeep Singh

CEO
SingleTimeMicroneedles
Panellists

Author:

Dan O'Neil

Associate Professor in Companion Animal Epidemiology
Royal Veterinary College, University of London

Dan O'Neil

Associate Professor in Companion Animal Epidemiology
Royal Veterinary College, University of London

Author:

David Singleton

Director of Research
IVC Evidensia

David Singleton

Director of Research
IVC Evidensia

Our panel of experienced animal health investors and deal makers will discuss their investment thesis, commercialisation and exit strategies.

Panellists

Author:

Spencer Swayze

Managing Director
Osiris Growth Capital

Spencer Swayze

Managing Director
Osiris Growth Capital

Author:

Dave Ross

Partner
Agrifood Investment Advisory LLP

Dave Ross

Partner
Agrifood Investment Advisory LLP

Author:

Wendy Furness

Director & Founder
Animal Health Angels

Wendy Furness

Director & Founder
Animal Health Angels

Author:

Julia Stephanus

Partner
Borealis Ventures

Julia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products.  She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010.  As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization.  Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco.  Aratana exited to Elanco in 2019.

Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals.  In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.

Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences.  Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.  

Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.

Julia Stephanus

Partner
Borealis Ventures

Julia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products.  She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010.  As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization.  Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco.  Aratana exited to Elanco in 2019.

Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals.  In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.

Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences.  Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.  

Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.

Industry partners most heavily involved in transactions across the ecosystem will share a data driven view of the market and discuss activity over the last 5 years and what we can expect in the next 5.

Moderator

Author:

Robert Darwin

Partner
Sidley Austin LLP

Robert Darwin

Partner
Sidley Austin LLP

Author:

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Key discussions points

  • Predictive disease modelling and early detection
  • AI to support smarter vaccine development and deployment
  • Interpretation of complex biological data (omics)
  • Training LLMs to summarize complex topics and specialized literature
  • Current AI-based tools for patent search and discovery

Author:

Sebastiano Busato

Associate Research Scientist
United Animal Health

Sebastiano Busato

Associate Research Scientist
United Animal Health

Author:

Nathan Horn

Scientific Discovery Lead
United Animal Health

Nathan Horn

Scientific Discovery Lead
United Animal Health